A Randomized, Double-blind, Single-dose, 2-Treatment, 2-Period, 2-Sequence Crossover Study to Compare Exposure and Activity of SAR342434 to Humalog Using the Euglycemic Clamp Technique, in Healthy Japanese Male Subjects
Latest Information Update: 15 Jun 2022
Price :
$35 *
At a glance
- Drugs Insulin lispro (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Sanofi K.K.
- 01 Jun 2022 Primary endpoint(Assessment of PD parameter: Maximum GIR) has been met, according to the results published in the Clinical Pharmacology in Drug Development.
- 01 Jun 2022 Primary endpoint(Assessment of PD parameter: Area under curve of glucose infusion rate (GIR)) has been met, according to the results published in the Clinical Pharmacology in Drug Development.
- 01 Jun 2022 Primary(Assessment of PK parameter: Maximum plasma concentration) endpoint has been met, according to the results published in the Clinical Pharmacology in Drug Development.